Medicamen Biotech consolidated net profit declines 16.15% in the September 2020 quarter
Sales decline 13.37% to Rs 30.77 crore
Net profit of Medicamen Biotech declined 16.15% to Rs 3.22 crore in the quarter ended September 2020 as against Rs 3.84 crore during the previous quarter ended September 2019. Sales declined 13.37% to Rs 30.77 crore in the quarter ended September 2020 as against Rs 35.52 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales30.7735.52 -13 OPM %18.0416.08 -PBDT5.305.84 -9 PBT4.605.22 -12 NP3.223.84 -16Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2020 | 2:32 PM IST